Psyma’s international medical marketing research business is undergoing reorganization in order to meet the demand for an ever more globally oriented scope of services and expertise. The new structure also prepares for the transition from Psyma International Medical’s founder, Matthias Fargel, who is handing over the strategic leadership of the worldwide Psyma Healthcare activities to Jeff Judek, presently COO of Psyma International Inc., USA, by the end of 2011.
Psyma operates local offices for healthcare research in Shanghai, Philadelphia, Mexico City, São Paolo and Moscow. In Western Europe, the main offices are in Nuremberg, Germany and Madrid, Spain. The German operations are led by Dr. Hubertus Meixner, supported by Mr. Marian Mihelic, Director Market Development & Consulting. In all countries, the domestic and international business units are now merged.
This strategic reorganization enables Psyma to offer its clientele an even broader spectrum of global and regional expertise with integrated resources in the European, Asian, North and Latin American markets.